SCHEMBL6765779

SCHEMBL6765779

CCCS(=O)(=O)NCC(C)c1ccc2cc(OCCNS(=O)(=O)c3ccccc3)ccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
HRAS P01112 1/20 0.51
KRAS P01116 1/20 0.51
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HTT P42858 1/20 0.48
TSHR P16473 1/20 0.47
GRIA4 P48058 2/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
CA9 Q16790 1/20 0.45
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 1/20 0.43
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6759350 0.92 GRIA4 (0.47) ALDH1A1HRASKRASHTTTSHR
SCHEMBL6763807 0.87 ALDH1A1 (0.47) ALDH1A1HRASKRASMEN1KMT2A
SCHEMBL6765777 0.86 ALDH1A1 (0.55) ALDH1A1HRASKRASMEN1KMT2A
SCHEMBL6761042 0.86 PPARG (0.55) KMT2AGRIA4KDM4ELMNA
SCHEMBL6762172 0.84 RAB9A (0.47) MEN1KMT2AGRIA4CA12CA1
SCHEMBL6766145 0.84 GRIA4 (0.43) ALDH1A1HRASKRASHTTTSHR
SCHEMBL6763723 0.83 GRIA4 (0.53) ALDH1A1MEN1KMT2AHTTTSHR
SCHEMBL6573583 0.83 GRIA4 (0.48) TSHRGRIA4CA12CA1CA2
SCHEMBL6763719 0.82 ACACB (0.47) ALDH1A1TSHRGRIA4CA12CA1
SCHEMBL6763170 0.81 GRIA4 (0.41) ALDH1A1HRASKRASKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 ALDH1A1 365/4885HRAS 3528/4885KRAS 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.